Results 1 to 10 of about 39,660 (245)

First report of gastroenteritis by genotype G12 rotavirus in Dakar, Senegal

open access: yesNew Microbes and New Infections, 2015
The genotype G12 rotavirus was isolated from the stool of children 5 years old or younger with acute gastroenteritis during 1 year in three Dakar hospitals. The G12 genotype was the most common (58.25%). VP4 genotyping revealed mixed genotypes (1.94%).
A Diop, M F Cissé
exaly   +4 more sources

Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis [PDF]

open access: yesJournal of Advanced Research
Introduction: Integrated proteogenomic studies of lung adenocarcinoma (LUAD) have provided unique insights with potential clinical effects. Comprehensive proteomic analyses are needed to better understand the molecular landscape of LUAD with KRAS G12 ...
Mei-Fang Zhang, Xiaoyi Yuan
exaly   +4 more sources

Role of G12 proteins in oncogenesis and metastasis [PDF]

open access: yesBritish Journal of Pharmacology, 2009
The G12 subfamily of heterotrimeric guanine nucleotide‐binding proteins consists of two α subunits, Gα12 and Gα13. These proteins mediate signalling via G protein‐coupled receptors and have been implicated in various physiological and pathophysiological processes.
Patrick J Casey
exaly   +3 more sources

The effect of uncertainty on the information content of term spread and its components [PDF]

open access: yesSeonmul yeongu, 2021
Purpose – This paper aims to investigate the impact of uncertainty on the predictive power of term spread and its components for future stock market returns and economic activity in Korea and the USA.
Jun Sik Kim
doaj   +1 more source

Extreme returns and idiosyncratic risks: evidence from an emerging market [PDF]

open access: yesSeonmul yeongu, 2021
In this paper, we show that there is a negative premium for MAX stocks in the Korean stock market. However, there is no evidence that the MAX effect overwhelms the effects of idiosyncratic risk.
Eunyoung Cho
doaj   +1 more source

Illiquidity, duration and momentum profits: evidence from the Korean stock market [PDF]

open access: yesSeonmul yeongu, 2021
This paper examines the role of illiquidity and duration factor in understanding the momentum profit in the Korean stock market. We find that the foreigner/institutional illiquidity factor explains the momentum effect.
Jaewan Bae, Changjun Lee
doaj   +1 more source

A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection

open access: yesmBio, 2022
Hepatitis B virus (HBV) infection is a serious global health issue with more than 250 million chronic carriers. It causes liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC).
Binfan Chen   +8 more
doaj   +1 more source

Do average higher moments predict aggregate returns in emerging stock markets? [PDF]

open access: yesJournal of Asian Business and Economic Studies, 2022
Purpose – It has been demonstrated in the US market that expected market excess returns can be predicted using the average higher-order moments of all firms. This study aims to empirically test this theory in emerging markets. Design/methodology/approach
Sumaira Chamadia   +2 more
doaj   +1 more source

Green bonds: a survey [PDF]

open access: yesSeonmul yeongu, 2020
This paper is a survey of recent academic developments in the literature on green bonds, which have become an important financial instrument in socially responsible investment. This study provides a review of papers that study the market pricing of green
Chiyoung Cheong, Jaewon Choi
doaj   +1 more source

G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion. [PDF]

open access: yesPLoS ONE, 2011
Signaling through the heterotrimeric G protein, G12, via Rho induces a striking increase in breast cancer cell invasion. In this study, evidence is provided that the c-Jun NH(2)-terminal kinase (JNK) is a key downstream effector of G12 on this pathway ...
Juhi Juneja   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy